Omalizumab Treatment of Vernal Keratoconjunctivitis

JAMA Ophthalmol. 2016 Apr;134(4):461-3. doi: 10.1001/jamaophthalmol.2015.5679.

Authors

Enrico Heffler¹, Giuseppe Picardi¹, Maria Teresa Liuzzo¹, Maria Provvidenza Pistorio¹, Nunzio Crimi¹

Affiliation

¹ Unit of Respiratory Medicine and Allergology, Department of Clinical and Experimental Medicine, Azienda Ospedaliero Universitaria Policlinico-Vittorio Emanuele Hospital, University of Catania, Catania, Italy.

PMID: 26795360
DOI: 10.1001/jamaophthalmol.2015.5679

No abstract available

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / administration & dosage*
Child
Conjunctivitis, Allergic / diagnosis*
Conjunctivitis, Allergic / drug therapy*
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Immunohistochemistry
Injections, Subcutaneous
Male
Omalizumab / administration & dosage*
Sampling Studies
Severity of Illness Index
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
Omalizumab